Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01393418 · ClinicalTrials.gov registry record
Evaluating Erythropoietin as an Indicator for Possible Kidney Injury After Cardiac Surgery
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 80
- Enrollment target
NCT01393418: Completed study, sponsored by University of Michigan.
NCT01393418 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01393418 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate kidney biomarkers and determine if there is a correlation between Erythropoietin (EPO) levels and acute kidney injury after cardiac surgery. An early biomarker for kidney injury may be helpful in identifying, monitoring and managing patients at risk for kidney failure after cardiac surgery. To evaluate Erythropoietin's role as a predictor of poor renal function in the immediate post-bypass period we plan to compare EPO levels to Neutrophil gelatinase-associated lipocalin (NGAL).
Interventions
- OTHER Cardiac Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-03 |
What the finished NCT01393418 record still lists
NCT01393418 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Surgery is the first listed.
NCT01393418 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01393418 about?
NCT01393418 is a clinical study titled "Evaluating Erythropoietin as an Indicator for Possible Kidney Injury After Cardiac Surgery". The purpose of the study is to evaluate kidney biomarkers and determine if there is a correlation between Erythropoietin (EPO) levels and acute kidney injury after cardiac surgery. An early biomarker for kidney injury may be helpful in identifying, monitoring and managing patients at risk for kidney...
What is the current status of trial NCT01393418?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2010-11. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01393418?
The interventions under investigation include: Cardiac Surgery (OTHER).
Who is sponsoring clinical trial NCT01393418?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia